Therapeutic Application of Phage Capsule Depolymerases against K1, K5, and K30 Capsulated E. coli in Mice
Capsule depolymerase enzymes offer a promising class of new antibiotics. In vivo studies are encouraging but it is unclear how well this type of phage product will generalize in therapeutics, or whether different depolymerases against the same capsule function similarly. Here, in vivo efficacy was t...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Frontiers Media S.A.
2017-11-01
|
| Sarja: | Frontiers in Microbiology |
| Aiheet: | |
| Linkit: | http://journal.frontiersin.org/article/10.3389/fmicb.2017.02257/full |
| Tagit: |
Ei tageja, Lisää ensimmäinen tagi!
|